Achieve Life Sciences, Inc. Prepaid Expense and Other Assets, Current
Achieve Life Sciences, Inc. (ACHV) had Prepaid Expense and Other Assets, Current of $1.94 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2025-11-06
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.94M.
- 2025-06-30: Prepaid Expense and Other Assets, Current $1.51M.
- 2025-03-31: Prepaid Expense and Other Assets, Current $1.75M.
- 2024-12-31: Prepaid Expense and Other Assets, Current $2.11M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2025-09-30 | $1.94M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.51M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.75M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.11M 10-Q · filed 2025-11-06 | |
| 2024-09-30 | $2.62M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.21M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.31M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $1.32M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $1.90M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $958.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.62M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $2.45M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.62M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.46M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.35M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.42M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $1.27M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $430.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $802.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.12M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $1.67M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $545.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $746.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $670.00K 10-K · filed 2021-03-11 | $662.00K 10-Q · filed 2020-05-14 |
| 2019-09-30 | $264.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $356.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $866.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $933.00K 10-Q · filed 2019-11-06 | |
| 2016-12-31 | $954.00K 10-K · filed 2017-02-23 | |
| 2016-09-30 | $1.65M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.30M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $1.58M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $1.99M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $1.60M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $2.03M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $3.01M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $2.17M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $2.46M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $2.29M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $1.82M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $5.77M 10-K · filed 2015-03-26 | |
| 2013-09-30 | $2.71M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $3.54M 10-Q · filed 2013-08-08 | |
| 2012-12-31 | $3.75M 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |